NephroSync™

Personalized Kidney Disease Trajectory Simulation

NephroSync™ is the first product currently under active development at BioTraject Systems.

NephroSync applies the BioTraject Systems Computational Medicine Platform to kidney disease with the goal of simulating how chronic kidney disease (CKD) evolves over time and how clinical interventions influence long-term outcomes.

Rather than generating a single risk score or static prediction, NephroSync is being designed to produce longitudinal, individualized disease trajectories that reflect the dynamic nature of kidney disease progression.

Why Kidney Disease

Kidney disease is a complex, chronic condition characterized by nonlinear progression, recurrent acute events, and strong interactions with metabolic and cardiovascular disease.

Clinical decisions in kidney care are often timing-sensitive:

When to intensify therapy
How to manage competing risks
When to prepare for dialysis or transplant
How comorbidities alter disease trajectories

These features make kidney disease an ideal first domain for trajectory-based simulation.

What NephroSync Aims to Do

NephroSync is being developed to support simulation-based exploration of kidney disease progression and intervention strategies.

The product is intended to:

Simulate individualized CKD trajectories over time
Model interactions among renal function, comorbidities, and acute events
Explore alternative intervention strategies virtually
Project downstream outcomes such as progression, dialysis, transplant, and mortality

NephroSync is not designed as a black-box predictor, but as a transparent simulation environment that clinicians and researchers can interrogate and understand.

Built on the BioTraject Systems Computational Medicine Platform

NephroSync is the first disease-specific implementation of the BioTraject Systems Computational Medicine Platform.

The platform architecture combines:

State-space representations of disease processes
Control-theoretic treatment of interventions
Hybrid AI methods for parameter estimation
Mechanistic simulation for interpretability

This foundation enables NephroSync to model kidney disease as a dynamic system rather than a sequence of isolated risk estimates.

Data Foundations

NephroSync is being developed and evaluated using curated longitudinal datasets, including:

EHR-derived real-world data

Observational cohort studies

Clinical trial datasets

Disease registries

These data sources support model development, calibration, sensitivity analyses, and external benchmarking within a research and development context.

Designed for Interpretability and Rigor

From the outset, NephroSync is being designed to meet high standards of scientific and clinical rigor.

Key design principles include:

Explicit model structures and assumptions
Transparent parameterization
Reproducible simulation workflows
Domain-specific validation strategies

Interpretability is treated as a core requirement, not an optional feature.

Who NephroSync Is Being Built For

NephroSync is being developed in collaboration with and for:

Nephrologists and multidisciplinary kidney care teams
Clinical researchers and epidemiologists
Health systems and research networks
Pharma and biotech partners engaged in kidney-focused development

Current Status

BioTraject Systems is currently:

Refining disease model structures
Developing parameter estimation pipelines
Implementing simulation and scenario-testing components
Engaging clinical and methodological advisors

Learn More

Technology – Explore the BioTraject Platform
Science & Validation – Learn about our validation framework
Company – Understand the mission behind BioTraject Systems

Contact us if you are interested in advising, collaborating, or exploring future pilot partnership